Total Payments
$6,478
2021 Payments
$965.46
Companies
37
Transactions
488
Medicare Patients
1,662
Medicare Billing
$148,965
Payment Breakdown by Category
Food & Beverage$6,259 (96.6%)
Education$219.78 (3.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,259 | 481 | 96.6% |
| Education | $219.78 | 7 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,148 | 66 | $0 (2021) |
| GlaxoSmithKline, LLC. | $736.59 | 62 | $0 (2021) |
| Novo Nordisk Inc | $645.88 | 58 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $579.76 | 70 | $0 (2021) |
| Amgen Inc. | $392.06 | 30 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $365.56 | 34 | $0 (2021) |
| Lilly USA, LLC | $342.04 | 23 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $315.80 | 22 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $282.39 | 17 | $0 (2021) |
| Astellas Pharma US Inc | $278.44 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $965.46 | 57 | GlaxoSmithKline, LLC. ($191.61) |
| 2020 | $778.46 | 53 | AstraZeneca Pharmaceuticals LP ($232.40) |
| 2019 | $1,337 | 94 | AstraZeneca Pharmaceuticals LP ($296.09) |
| 2018 | $1,546 | 124 | AstraZeneca Pharmaceuticals LP ($297.98) |
| 2017 | $1,852 | 160 | Lilly USA, LLC ($271.73) |
All Payment Transactions
488 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: DIABETES | ||||||
| 10/20/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Cardiovascular | ||||||
| 10/18/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Diabetes | ||||||
| 10/11/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardio-renal | ||||||
| 09/22/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
| 09/15/2021 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: VACCINES | ||||||
| 09/08/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: Obesity | ||||||
| 08/31/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes | ||||||
| 08/18/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Neuroscience | ||||||
| 08/17/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: PRIMARY CARE | ||||||
| 08/11/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: RESPIRATORY | ||||||
| 08/05/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Obesity | ||||||
| 08/04/2021 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $7.60 | General |
| Category: VACCINES | ||||||
| 07/27/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Diabetes | ||||||
| 06/30/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: RESPIRATORY | ||||||
| 06/22/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: DIABETES | ||||||
| 06/21/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: PRIMARY CARE | ||||||
| 06/17/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 12 | 717 | 947 | $123,967 | $69,478 |
| 2020 | 16 | 945 | 1,240 | $158,690 | $79,487 |
Total Patients
1,662
Total Services
2,187
Medicare Billing
$148,965
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 249 | 409 | $65,440 | $35,159 | 53.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 95 | 95 | $17,100 | $12,622 | 73.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 149 | 200 | $22,400 | $11,901 | 53.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 18 | 18 | $5,400 | $3,030 | 56.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 39 | 39 | $2,675 | $2,542 | 95.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 27 | 34 | $2,890 | $1,357 | 47.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,185 | $1,208 | 37.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 38 | 38 | $1,330 | $646.13 | 48.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 43 | 52 | $1,300 | $496.62 | 38.2% |
| 90471 | Administration of 1 vaccine | Office | 2021 | 22 | 24 | $1,080 | $271.93 | 25.2% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 12 | 13 | $975.00 | $217.52 | 22.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 12 | 12 | $192.00 | $27.00 | 14.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 279 | 494 | $79,040 | $37,863 | 47.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 54 | 54 | $16,200 | $9,192 | 56.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 118 | 166 | $18,715 | $8,484 | 45.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 71 | 71 | $12,780 | $8,218 | 64.3% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 71 | 71 | $4,920 | $4,330 | 88.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 93 | 112 | $9,520 | $3,153 | 33.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 20 | 20 | $4,300 | $2,048 | 47.6% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 14 | 14 | $2,100 | $1,647 | 78.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 84 | 84 | $2,940 | $1,406 | 47.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $2,695 | $1,392 | 51.6% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 41 | 52 | $1,300 | $493.81 | 38.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 23 | 23 | $805.00 | $383.10 | 47.6% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 17 | 17 | $1,275 | $242.91 | 19.1% |
About Dr. Rajul Malik, MD
Dr. Rajul Malik, MD is a Internal Medicine healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376517607.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rajul Malik, MD has received a total of $6,478 in payments from pharmaceutical and medical device companies, with $965.46 received in 2021. These payments were reported across 488 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,259).
As a Medicare-enrolled provider, Malik has provided services to 1,662 Medicare beneficiaries, totaling 2,187 services with total Medicare billing of $148,965. Data is available for 2 years (2020–2021), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Virginia Beach, VA
- Active Since 02/14/2006
- Last Updated 04/12/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1376517607
Products in Payments
- TRELEGY ELLIPTA (Drug) $448.11
- FARXIGA (Drug) $431.53
- JANUVIA (Drug) $373.59
- BEVESPI AEROSPHERE (Drug) $324.80
- Ozempic (Drug) $312.12
- XARELTO (Drug) $240.11
- JARDIANCE (Drug) $227.30
- TRULICITY (Drug) $223.06
- SYMBICORT (Drug) $155.42
- Aimovig (Biological) $147.26
- ANORO (Drug) $130.72
- CHANTIX (Drug) $128.43
- INVOKANA (Drug) $125.45
- TOUJEO (Drug) $115.45
- Victoza (Drug) $115.25
- STIOLTO RESPIMAT (Drug) $105.17
- BREZTRI (Drug) $104.98
- NURTEC ODT (Drug) $102.47
- Repatha (Biological) $100.45
- Prolia (Biological) $99.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Virginia Beach
Dr. Garfield Samuels, M.d, M.D
Internal Medicine — Payments: $144,009
Internal Medicine $144,009
Anthony Amabile, Md, MD
Internal Medicine — Payments: $13,478
Internal Medicine $13,478
Herbert Knight, M.d, M.D
Internal Medicine — Payments: $11,019
Internal Medicine $11,019
Dr. David Haden, M.d, M.D
Internal Medicine — Payments: $9,475
Internal Medicine $9,475
Vera Goode, Md, MD
Internal Medicine — Payments: $8,369
Internal Medicine $8,369
Susan Ring, Md, MD
Internal Medicine — Payments: $5,413
Internal Medicine $5,413